This document discusses corporate responsibilities for the right to health. It outlines how businesses are expected to respect human rights and not be complicit in human rights abuses according to the UN Global Compact. It also discusses how the Universal Declaration of Human Rights and the International Covenant on Economic, Social and Cultural Rights establish the right to health. The document argues that applied corporate responsibility for access to medicines can save lives, position companies as part of the solution to social issues, and enhance employee motivation and attraction for partnerships.
Sickness Funds and the Pharmaceutical Industry: a New Relationship?Beapp_Bcpm
On Friday 3rd March, Dr Jan Van Emelen, Innovation Director at Neutral Mutualities presented on “Mutualities and pharmaceutical industry: a new relationship?”. Access to new, often very expensive medications is a hot topic and our speaker discussed the role of the mutualities in this process, using new models for disease management. He shared ideas on our potential interaction with this process as pharmaceutical physicians.
The document outlines objectives for a nursing fundamentals course focusing on health care delivery and professional nursing. It discusses the current U.S. health care delivery system, the role of nursing within it, and different levels of health care providers. It also covers primary, secondary, and tertiary health care services; diversity in health care; trends in health care delivery systems; and examples of health care institutions and practitioners.
Material de (1) la conferencia “La E-Salud en mundo global” realizada el 17 de febrero de 2.012 por el Sr. Joan Cornet, Presidente Ejecutivo de la Fundación TicSalud (1er ciclo de conferencias en el ámbito TIC-Salud organizado por las Escuelas Universitarias de Informática y de Enfermería con la colaboración de la Fundación Tic-Salud, en el marco del Máster Oficial en Gestión de la Información y el Conocimiento en el Ámbito de la Salud)
La ciencia y la tecnología no tienen fronteras en un mundo global en el que están apareciendo innovaciones por todas partes. La eSalud tiene por vocación dar mejores servicios en el seno de los sistemas de salud. A pesar de las diferencias culturales, lingüísticas y de práctica de la medicina, el ser humano y la salud se convierten en lo mismo en todas partes. Las nuevas tecnologías permiten la comunicación rápida, la compartición de experiencias, el aprendizaje de las mejores prácticas y el contraste de resultados. Por eso la implementación de procesos de eSalud es un fenómeno de alcance local, pero su éxito depende del conocimiento global. Es por ello que cada vez hay más redes y organizaciones que facilitan la transferencia de conocimiento y el compilado de las mejores prácticas. El reto, pues, tanto para las organizaciones sanitarias como para las universidades y empresas innovadoras es lograr que las TICs, una vez probadas y homologadas, sean implementadas en los servicios de salud. Todo un reto tecnológico, legal, ético y financiero.
La conferencia fue impartida por el Sr. Joan Cornet, Presidente Ejecutivo de la Fundación TicSalud. El Sr. Cornet es Ingeniero técnico y Licenciado en psicología. A lo largo de su dilatada experiencia profesional, ha ocupado los cargos de Presidente Consorcio Hospitalario de Cataluña, Vicepresidente de la Federación de Municipios de Cataluña y Coordinador de la Comisión de Sanidad y Servicios Sociales de la FEMP, alto funcionario en la Comisión Europea , y Secretario General del Departamento de Salud de la Generalitat de Catalunya. En septiembre 2005 el Gobierno le encargó la puesta en marcha de la Bioregión de Cataluña y desde Enero 2007 por encargo del Departamento de Salud está al frente de la Fundación TicSalut.
The document discusses capacity building in the public health sector of Chhattisgarh, India. It notes that capacity building refers to creating, expanding, or upgrading desired capabilities that can be drawn on over time, rather than just managing existing resources. It provides statistics on Chhattisgarh's population and health infrastructure, noting a large rural population and shortage of facilities. It also outlines issues with training capacity, quality, and rationalizing trained human resources. It discusses the state's policy decisions around strengthening training institutions and prioritizing certain programs to build capacity in the public health workforce.
This document discusses the role of evidence and global partnerships in addressing major global health issues and achieving the UN Millennium Development Goals. It outlines how organizations like the World Health Organization, World Bank, and Lancet work together through initiatives like Countdown 2015 and strategic partnerships to generate scientific evidence, advocate for policies, and monitor programs aimed at reducing child and maternal mortality globally. The document also previews upcoming reports from the Lancet on various global health topics like mental health, HIV prevention, and non-communicable diseases.
This document summarizes opportunities for patient and caregiver involvement in technology appraisals conducted by the National Institute for Health and Clinical Excellence (NICE) in the UK. It outlines when patients can provide input throughout the appraisal process, including topic suggestion, scoping, evidence submission and review, and committee meetings. Patient groups and individuals can comment on draft documents and attend meetings. The document also reviews what information patients provide, such as personal impacts, outcomes, and experiences using technologies. Finally, it discusses challenges of patient involvement and feedback from surveys and interviews, with some patients feeling their views are not weighted equally and processes can be intimidating.
The document discusses requirements for a new Cochrane Register of Studies database system. It outlines the objectives to clarify and prioritize business and technical requirements, produce a request for proposal (RFP) document, and a scoring guide for responses. A requirements catalog and high-level architecture diagrams were produced. Requirements were prioritized using MoSCoW rules. The document considers alternative options to a complex bespoke system like using a commercial off-the-shelf package to address the core problems of data duplication, search functionality, and workflow issues.
This document summarizes a consultation regarding requirements for a new Cochrane Register of Studies database system. It outlines the objectives to clarify and prioritize business and technical requirements to produce a request for proposal. It describes the approach taken, including reviewing existing requirements, producing a requirements catalogue and high-level architecture diagrams. It then presents the findings, including "As-Is" and "To-Be" high-level architecture diagrams, a conceptual solution overview, example technologies that could be used, and the results of requirements prioritization. It concludes by discussing next steps around the request for proposal, but also raises questions about potentially simpler alternatives to meet core needs.
Sickness Funds and the Pharmaceutical Industry: a New Relationship?Beapp_Bcpm
On Friday 3rd March, Dr Jan Van Emelen, Innovation Director at Neutral Mutualities presented on “Mutualities and pharmaceutical industry: a new relationship?”. Access to new, often very expensive medications is a hot topic and our speaker discussed the role of the mutualities in this process, using new models for disease management. He shared ideas on our potential interaction with this process as pharmaceutical physicians.
The document outlines objectives for a nursing fundamentals course focusing on health care delivery and professional nursing. It discusses the current U.S. health care delivery system, the role of nursing within it, and different levels of health care providers. It also covers primary, secondary, and tertiary health care services; diversity in health care; trends in health care delivery systems; and examples of health care institutions and practitioners.
Material de (1) la conferencia “La E-Salud en mundo global” realizada el 17 de febrero de 2.012 por el Sr. Joan Cornet, Presidente Ejecutivo de la Fundación TicSalud (1er ciclo de conferencias en el ámbito TIC-Salud organizado por las Escuelas Universitarias de Informática y de Enfermería con la colaboración de la Fundación Tic-Salud, en el marco del Máster Oficial en Gestión de la Información y el Conocimiento en el Ámbito de la Salud)
La ciencia y la tecnología no tienen fronteras en un mundo global en el que están apareciendo innovaciones por todas partes. La eSalud tiene por vocación dar mejores servicios en el seno de los sistemas de salud. A pesar de las diferencias culturales, lingüísticas y de práctica de la medicina, el ser humano y la salud se convierten en lo mismo en todas partes. Las nuevas tecnologías permiten la comunicación rápida, la compartición de experiencias, el aprendizaje de las mejores prácticas y el contraste de resultados. Por eso la implementación de procesos de eSalud es un fenómeno de alcance local, pero su éxito depende del conocimiento global. Es por ello que cada vez hay más redes y organizaciones que facilitan la transferencia de conocimiento y el compilado de las mejores prácticas. El reto, pues, tanto para las organizaciones sanitarias como para las universidades y empresas innovadoras es lograr que las TICs, una vez probadas y homologadas, sean implementadas en los servicios de salud. Todo un reto tecnológico, legal, ético y financiero.
La conferencia fue impartida por el Sr. Joan Cornet, Presidente Ejecutivo de la Fundación TicSalud. El Sr. Cornet es Ingeniero técnico y Licenciado en psicología. A lo largo de su dilatada experiencia profesional, ha ocupado los cargos de Presidente Consorcio Hospitalario de Cataluña, Vicepresidente de la Federación de Municipios de Cataluña y Coordinador de la Comisión de Sanidad y Servicios Sociales de la FEMP, alto funcionario en la Comisión Europea , y Secretario General del Departamento de Salud de la Generalitat de Catalunya. En septiembre 2005 el Gobierno le encargó la puesta en marcha de la Bioregión de Cataluña y desde Enero 2007 por encargo del Departamento de Salud está al frente de la Fundación TicSalut.
The document discusses capacity building in the public health sector of Chhattisgarh, India. It notes that capacity building refers to creating, expanding, or upgrading desired capabilities that can be drawn on over time, rather than just managing existing resources. It provides statistics on Chhattisgarh's population and health infrastructure, noting a large rural population and shortage of facilities. It also outlines issues with training capacity, quality, and rationalizing trained human resources. It discusses the state's policy decisions around strengthening training institutions and prioritizing certain programs to build capacity in the public health workforce.
This document discusses the role of evidence and global partnerships in addressing major global health issues and achieving the UN Millennium Development Goals. It outlines how organizations like the World Health Organization, World Bank, and Lancet work together through initiatives like Countdown 2015 and strategic partnerships to generate scientific evidence, advocate for policies, and monitor programs aimed at reducing child and maternal mortality globally. The document also previews upcoming reports from the Lancet on various global health topics like mental health, HIV prevention, and non-communicable diseases.
This document summarizes opportunities for patient and caregiver involvement in technology appraisals conducted by the National Institute for Health and Clinical Excellence (NICE) in the UK. It outlines when patients can provide input throughout the appraisal process, including topic suggestion, scoping, evidence submission and review, and committee meetings. Patient groups and individuals can comment on draft documents and attend meetings. The document also reviews what information patients provide, such as personal impacts, outcomes, and experiences using technologies. Finally, it discusses challenges of patient involvement and feedback from surveys and interviews, with some patients feeling their views are not weighted equally and processes can be intimidating.
The document discusses requirements for a new Cochrane Register of Studies database system. It outlines the objectives to clarify and prioritize business and technical requirements, produce a request for proposal (RFP) document, and a scoring guide for responses. A requirements catalog and high-level architecture diagrams were produced. Requirements were prioritized using MoSCoW rules. The document considers alternative options to a complex bespoke system like using a commercial off-the-shelf package to address the core problems of data duplication, search functionality, and workflow issues.
This document summarizes a consultation regarding requirements for a new Cochrane Register of Studies database system. It outlines the objectives to clarify and prioritize business and technical requirements to produce a request for proposal. It describes the approach taken, including reviewing existing requirements, producing a requirements catalogue and high-level architecture diagrams. It then presents the findings, including "As-Is" and "To-Be" high-level architecture diagrams, a conceptual solution overview, example technologies that could be used, and the results of requirements prioritization. It concludes by discussing next steps around the request for proposal, but also raises questions about potentially simpler alternatives to meet core needs.
MEDICA MEDIA FORUM
„ePatient/Health 2.0: Schlüsselfaktor für neue, zukunftsfähige Geschäftsmodelle der Life Sciences Industrie“
Impulsreferat von Matthias Wartenberg, Executive Director Advisory Service LifeScience, Ernst & Young, Eschborn
At the center of smarter life sciencesis an increasingly more networked operation focused on the end patient. The result is also a safe, effective and valued treatment solution targeted at the patient.
Personalised healthcare short guide (for web)benj_2
The document discusses various developments in medical profiling and online medicine, and explores their ethical implications. It analyzes case studies of online health information, online personal health records, buying medicines online, telemedicine, personal genetic profiling, and body imaging. For each case, it discusses potential benefits but also risks or harms, and provides recommendations aimed at maximizing benefits and minimizing harms in a way that respects various ethical values around privacy, individual autonomy, reducing harm, fairness, and social solidarity.
Boosting drug development through public private partnerships (Laverty OECD P...Per Koch
Presentation from the conference Science diplomacy in action Governance for international science co-operation: the example of Health Research 11-12 February, 2013, arranged by the French and British embassies as a follow up to the OECD STIG project, see http://beyondstig.oecd.org
The document discusses integrating basic occupational health services (BOSH) into primary healthcare (PHC) systems to serve underserved worker groups. It notes that about 50% of the global workforce is in informal or vulnerable employment with high risks and little access to services. Integrating BOSH into PHC could leverage existing infrastructure to deliver essential interventions affordably and accessibly. The document reviews country experiences integrating BOSH and PHC in places like Thailand, Indonesia, China, Brazil, India, and Chile. Key challenges include the informal nature of many jobs, exclusion from protections, and lack of data on the impacts of occupational illnesses and injuries.
The document discusses the 2001 report "Crossing the Quality Chasm" which proposed a framework for redesigning the U.S. healthcare system. It identified six aims for improvement: safety, effectiveness, patient-centeredness, timeliness, efficiency, and equity. The report argued that achieving these aims would require improved organization of care delivery, better access to clinical evidence, and changes to payment systems. It outlined strategies like care coordination, health IT adoption, and quality improvement to help transition the system toward a patient-centered model. The implications discussed are that providers in 2008 should focus on clinical transformation, the patient-centered care model, and following the report's ten rules to help bridge the quality gap.
PANEL 2: Endocrine disruptors as a challenge for risk communication
Presentation: Martin Kayser, Senior Vice President of Product Safety, BASF, Germany
mHealth Applications: Current Projects and their Status: Understanding the 12 Application Clusters of mHealth by C. Peter Waegemann, Executive Director, mHealth Initiative
iMinds insights on citizen health empowermentiMindsinsights
As more people are living longer than before and with chronic disease on the rise, disease prevention alone is no longer enough. Citizens need to take more control over their health – by giving them greater access to their personal health information and equipping them with tools and insights to better manage their lifestyles.
iMinds insights is a quarterly publication providing you with relevant tech updates based on interviews with academic and industry experts. iMinds is a digital research center and incubator based in Belgium.
Joint Commission and Patients for Patient Safety. Laura Botwinick. III International Conference on Patient Safety: "Patients for Patient Safety" (Madrid, Ministry of Health and Consumer Affairs, 2007)
The document discusses pharmaceutical companies entering social media and online patient communities. It notes opportunities for non-branded disease awareness campaigns and collaborating with patient advocacy groups. Examples are given of companies like GSK, J&J, and Pfizer creating educational video and online content to engage patients without being overtly promotional. Special focus is given to engaging micro-patient communities for rare diseases through foundations and online support groups.
The document discusses improving access to essential medicines and identifies several problems. It notes that two billion people lack access to essential medicines, and there is a large price variation for treatments between countries. Stockouts of essential medicines also occur when health facilities experience shortages. The document proposes several solutions, including greater use of generics, changing how innovation is rewarded, improving governance and transparency, and partnerships between different stakeholders.
Eco friendly: The emerging life sciences ecosystem Heather Fraser
Pharma and life sciences collaborations will be taken to a whole new level as emerging ecosystems shake up traditional practices. The emphasis on operations for mutual self-interest and broader benefit will spur openness to innovate and the free flow of ideas and resources.
Roots of Public Health Nursing FNU Essay.docxwrite31
Public health nursing has its roots in efforts to improve sanitation and health conditions dating back to early civilizations. In the 19th century, reforms in England and initiatives in America by nurses like Clara Barton and Lillian Wald helped establish public health nursing. Public health nursing aims to promote health and prevent disease in populations through strategies that address social and environmental factors. Today, public health nurses face challenges of embracing new technologies, engaging in evidence-based practices, and addressing evolving health issues.
Using technology-enabled social prescriptions to disrupt healthcareDr Sven Jungmann
As chronic diseases are increasingly straining healthcare systems, social factors are gaining importance. Since the birth of social medicine (19th century), we saw many failed attempts to beat the dominance of the biomedical model. Social prescriptions have come, raising hopes that non-biomedical solutions will improve outcomes and optimise resource use. Social Prescriptions connect citizens to support to address social determinants of health and encourage self-care for physical and mental health. Social prescriptions can make us healthier cheaper and with fewer side effects than most drugs. Social prescriptions can become a disruptive force as they can be personalised, improve lifestyle-related diseases, and support non-biomedical issues affected by social determinants of health.
Minnesota has a growing Tissue & Biologics sector developing unique regenerative medicine products. The sector includes 114 companies distributed across therapeutics, biobanks, tools/diagnostics, and support/services. Therapeutics and support/services are most developed, with companies advancing areas like orthopedics, scaffolds, and cardiovascular disease. Minnesota leverages strengths in biomaterials and tissue engineering to establish itself as a global leader in this industry.
The document discusses the concepts of community health and development, primary health care, and the role of community health nursing. It provides definitions and principles of primary health care and community health nursing according to global organizations. The key points are:
- Primary health care aims to provide basic health services universally and affordably through community participation.
- Community health nursing focuses on health promotion, prevention and rehabilitation by considering various social, economic and environmental factors that influence health.
- The principles of primary health care and strategies of community health nursing emphasize accessibility, community involvement, self-reliance and addressing health's relationship with development.
The document discusses the concepts of community health and development, primary health care, and the role of community health nursing. It provides definitions and principles of primary health care and community health nursing according to global organizations. The three key points are: 1) Primary health care aims to provide basic health services universally and affordably through community participation and self-reliance. 2) Community health nursing focuses on health promotion, prevention and rehabilitation through collaboration with communities and populations. 3) Community health and development are influenced by social, economic, political and environmental factors and require multisectoral collaboration.
This document summarizes the goals and progress of Cochrane's Strategy to 2020. It has four main goals: 1) Producing high-quality systematic reviews, 2) Making evidence accessible worldwide, 3) Advocating for evidence-informed healthcare, and 4) Building an effective and sustainable organization. In 2015, Cochrane achieved many milestones, including a new brand and multilingual website, increasing access to reviews, and partnerships to increase the impact of evidence on guidelines and policies. In 2016, Cochrane will continue projects to improve technology, business processes, and membership while delivering the Strategy to 2020.
MEDICA MEDIA FORUM
„ePatient/Health 2.0: Schlüsselfaktor für neue, zukunftsfähige Geschäftsmodelle der Life Sciences Industrie“
Impulsreferat von Matthias Wartenberg, Executive Director Advisory Service LifeScience, Ernst & Young, Eschborn
At the center of smarter life sciencesis an increasingly more networked operation focused on the end patient. The result is also a safe, effective and valued treatment solution targeted at the patient.
Personalised healthcare short guide (for web)benj_2
The document discusses various developments in medical profiling and online medicine, and explores their ethical implications. It analyzes case studies of online health information, online personal health records, buying medicines online, telemedicine, personal genetic profiling, and body imaging. For each case, it discusses potential benefits but also risks or harms, and provides recommendations aimed at maximizing benefits and minimizing harms in a way that respects various ethical values around privacy, individual autonomy, reducing harm, fairness, and social solidarity.
Boosting drug development through public private partnerships (Laverty OECD P...Per Koch
Presentation from the conference Science diplomacy in action Governance for international science co-operation: the example of Health Research 11-12 February, 2013, arranged by the French and British embassies as a follow up to the OECD STIG project, see http://beyondstig.oecd.org
The document discusses integrating basic occupational health services (BOSH) into primary healthcare (PHC) systems to serve underserved worker groups. It notes that about 50% of the global workforce is in informal or vulnerable employment with high risks and little access to services. Integrating BOSH into PHC could leverage existing infrastructure to deliver essential interventions affordably and accessibly. The document reviews country experiences integrating BOSH and PHC in places like Thailand, Indonesia, China, Brazil, India, and Chile. Key challenges include the informal nature of many jobs, exclusion from protections, and lack of data on the impacts of occupational illnesses and injuries.
The document discusses the 2001 report "Crossing the Quality Chasm" which proposed a framework for redesigning the U.S. healthcare system. It identified six aims for improvement: safety, effectiveness, patient-centeredness, timeliness, efficiency, and equity. The report argued that achieving these aims would require improved organization of care delivery, better access to clinical evidence, and changes to payment systems. It outlined strategies like care coordination, health IT adoption, and quality improvement to help transition the system toward a patient-centered model. The implications discussed are that providers in 2008 should focus on clinical transformation, the patient-centered care model, and following the report's ten rules to help bridge the quality gap.
PANEL 2: Endocrine disruptors as a challenge for risk communication
Presentation: Martin Kayser, Senior Vice President of Product Safety, BASF, Germany
mHealth Applications: Current Projects and their Status: Understanding the 12 Application Clusters of mHealth by C. Peter Waegemann, Executive Director, mHealth Initiative
iMinds insights on citizen health empowermentiMindsinsights
As more people are living longer than before and with chronic disease on the rise, disease prevention alone is no longer enough. Citizens need to take more control over their health – by giving them greater access to their personal health information and equipping them with tools and insights to better manage their lifestyles.
iMinds insights is a quarterly publication providing you with relevant tech updates based on interviews with academic and industry experts. iMinds is a digital research center and incubator based in Belgium.
Joint Commission and Patients for Patient Safety. Laura Botwinick. III International Conference on Patient Safety: "Patients for Patient Safety" (Madrid, Ministry of Health and Consumer Affairs, 2007)
The document discusses pharmaceutical companies entering social media and online patient communities. It notes opportunities for non-branded disease awareness campaigns and collaborating with patient advocacy groups. Examples are given of companies like GSK, J&J, and Pfizer creating educational video and online content to engage patients without being overtly promotional. Special focus is given to engaging micro-patient communities for rare diseases through foundations and online support groups.
The document discusses improving access to essential medicines and identifies several problems. It notes that two billion people lack access to essential medicines, and there is a large price variation for treatments between countries. Stockouts of essential medicines also occur when health facilities experience shortages. The document proposes several solutions, including greater use of generics, changing how innovation is rewarded, improving governance and transparency, and partnerships between different stakeholders.
Eco friendly: The emerging life sciences ecosystem Heather Fraser
Pharma and life sciences collaborations will be taken to a whole new level as emerging ecosystems shake up traditional practices. The emphasis on operations for mutual self-interest and broader benefit will spur openness to innovate and the free flow of ideas and resources.
Roots of Public Health Nursing FNU Essay.docxwrite31
Public health nursing has its roots in efforts to improve sanitation and health conditions dating back to early civilizations. In the 19th century, reforms in England and initiatives in America by nurses like Clara Barton and Lillian Wald helped establish public health nursing. Public health nursing aims to promote health and prevent disease in populations through strategies that address social and environmental factors. Today, public health nurses face challenges of embracing new technologies, engaging in evidence-based practices, and addressing evolving health issues.
Using technology-enabled social prescriptions to disrupt healthcareDr Sven Jungmann
As chronic diseases are increasingly straining healthcare systems, social factors are gaining importance. Since the birth of social medicine (19th century), we saw many failed attempts to beat the dominance of the biomedical model. Social prescriptions have come, raising hopes that non-biomedical solutions will improve outcomes and optimise resource use. Social Prescriptions connect citizens to support to address social determinants of health and encourage self-care for physical and mental health. Social prescriptions can make us healthier cheaper and with fewer side effects than most drugs. Social prescriptions can become a disruptive force as they can be personalised, improve lifestyle-related diseases, and support non-biomedical issues affected by social determinants of health.
Minnesota has a growing Tissue & Biologics sector developing unique regenerative medicine products. The sector includes 114 companies distributed across therapeutics, biobanks, tools/diagnostics, and support/services. Therapeutics and support/services are most developed, with companies advancing areas like orthopedics, scaffolds, and cardiovascular disease. Minnesota leverages strengths in biomaterials and tissue engineering to establish itself as a global leader in this industry.
The document discusses the concepts of community health and development, primary health care, and the role of community health nursing. It provides definitions and principles of primary health care and community health nursing according to global organizations. The key points are:
- Primary health care aims to provide basic health services universally and affordably through community participation.
- Community health nursing focuses on health promotion, prevention and rehabilitation by considering various social, economic and environmental factors that influence health.
- The principles of primary health care and strategies of community health nursing emphasize accessibility, community involvement, self-reliance and addressing health's relationship with development.
The document discusses the concepts of community health and development, primary health care, and the role of community health nursing. It provides definitions and principles of primary health care and community health nursing according to global organizations. The three key points are: 1) Primary health care aims to provide basic health services universally and affordably through community participation and self-reliance. 2) Community health nursing focuses on health promotion, prevention and rehabilitation through collaboration with communities and populations. 3) Community health and development are influenced by social, economic, political and environmental factors and require multisectoral collaboration.
Similar to Corporate responsibility for the right to health (20)
This document summarizes the goals and progress of Cochrane's Strategy to 2020. It has four main goals: 1) Producing high-quality systematic reviews, 2) Making evidence accessible worldwide, 3) Advocating for evidence-informed healthcare, and 4) Building an effective and sustainable organization. In 2015, Cochrane achieved many milestones, including a new brand and multilingual website, increasing access to reviews, and partnerships to increase the impact of evidence on guidelines and policies. In 2016, Cochrane will continue projects to improve technology, business processes, and membership while delivering the Strategy to 2020.
This document discusses the impact of translating Cochrane reviews into other languages. It finds that Spanish and French translations see tens of thousands of page views and visits each month, accounting for 10-15% and 15-20% of total summaries traffic respectively. Translations help reach new audiences, as evidenced by France now ranking second in country statistics. While the impact is smaller, Portuguese and Croatian translations also see usage and audience increases as more reviews are translated. The top languages for translations are Spanish, French and Portuguese, matching the number of speakers of those languages globally.
This document discusses how linked data and other futuristic technologies can enhance the dissemination of systematic reviews beyond static PDF documents. It notes that linked data, combined with text mining, has potential to improve the production of systematic reviews as well. The document discusses how linked data can improve the reading experience by allowing readers to control their experience of content through concept-based exploration of fact-based information and networks of documents interconnected by concepts rather than just characters. This represents a shift from documents being the focus to the concepts and knowledge they contain.
1. The document discusses how cheap data is changing how knowledge is formed and discussed the increasing generativity of data sets through greater accessibility, adaptability, leverage, and ease of use.
2. It notes that collaboration and sharing of data will be necessary and discusses the potential for patient data to enable unanticipated discoveries through broad contributions.
3. Integrating most patient data is seen as mostly non-generative currently but examples of collaborations on generative data are mentioned as proving collaboration is possible. Concerns about privacy and appropriate use are also raised.
The document summarizes a lightning session on tools and interfaces for systematic reviews presented by Jessica Thomas and Jacob Riis from Silos Inc. It discusses Cochrane's current tools like RevMan and Archie. It also talks about the need to make authoring more efficient and flexible, improve automation using tools like CRS and RevMan, and leverage primary studies to automatically feed into systematic reviews as they develop in order to create "tasty data". The presentation sought feedback on improving existing resources and developing new tools and approaches.
The document discusses leveraging technology to improve the Cochrane review process and better deliver evidence to end-users. It proposes moving from a traditional review model to a continuous learning model that incorporates individual patient data, produces more personalized evidence, and accounts for rapidly evolving digital technologies and health apps. Specific ideas include using n-of-1 trials for chronic pain, evaluating eHealth interventions during development, and conducting large virtual cohort studies using diverse data sources. The goal is to generate the most sound individual and population-level evidence through open, linked data and continuous review methods.
This document discusses how machine learning and natural language processing techniques can help automate parts of the systematic review process. It notes that the volume of literature is growing rapidly, necessitating new approaches. Specifically, machine learning classifiers like support vector machines can be trained on labeled examples to screen abstracts and select potentially relevant papers, reducing the manual burden. However, imbalanced data and reviewer time constraints require approaches like active learning and dual supervision. The document concludes by suggesting text mining could also aid other review tasks beyond citation screening.
Crowdsourcing uses online platforms like Amazon Mechanical Turk to distribute simple tasks to many workers. Zooniverse is a platform that uses crowdsourcing for scientific research projects, ensuring tasks contribute to real research. Citizen science websites like SciStarter allow volunteers to participate in various science projects. Cochrane could use crowdsourcing to speed up reviewing literature for systematic reviews by breaking tasks into smaller pieces distributed to many volunteers, as long as tasks are clinically relevant and volunteers are motivated and supported.
The document discusses the future of Cochrane Reviews and scientific articles moving away from static documents toward structured linked data and interfaces. It argues that the focus should shift from the documents themselves to the things they are about (e.g. populations, interventions, outcomes), which can be connected as a web of data. This would allow content to be more nimble, traveling freely across datasets while retaining context. Interfaces could provide better access than documents by enabling smart search and filtering of this linked data graph. The future is making content and delivery more important than the containers (documents/articles) themselves.
Professor Marcus Müllner of the Austrian Agency for Health and Food Safety (AGES) presents "Does evidence-based decision making exist?" at the opening of the Austrian Cochrane Branch on December 14th, 2010 in Krems.
Professor Ruth Gilbert of University College London presents "Could a systematic review have prevented the epidemic of sudden infant death syndrome?" at the opening of the Austrian Cochrane Branch in Krems, Austria, on December 14th 2010.
Systematic reviews aim to reduce bias and provide accurate information about healthcare interventions by synthesizing evidence from multiple studies. Their evolution began in the early 20th century with early statistical meta-analyses. Later, Archie Cochrane advocated for regularly updating specialized reviews of randomized controlled trials to inform clinical practice. This led to the formation of the Cochrane Collaboration in the 1990s to produce freely accessible systematic reviews and promote evidence-based healthcare worldwide.
Dr. Gerd Antes, Director of the German Cochrane Centre, presents "Evidenz ist essentiell - von der Idee zum globalen Netzwerk: Die Cochrane Collaboration".
Cochrane Database of Systematic Reviews: Indexing, Citations & BibliometricsCochrane.Collaboration
This document discusses bibliometrics and the impact factor calculation. It provides details on:
- How the impact factor is calculated based on citations to recent articles over a two year period.
- Some strengths and weaknesses of using the impact factor as a metric.
- An example impact factor calculation for a journal using 2008 and 2009 citation and article data.
- How Web of Science collects and analyzes journal data including bibliographic information and citation reports.
- Challenges in acquiring and cleaning up Cochrane Database of Systematic Reviews citation and publication data from Web of Science.
- Key findings from analyzing CDSR's citation and author data, including high author loyalty to the journal.
1. Corporate Responsibilities for
the Right to Health
16th Cochrane Colloquium
Freiburg im Breisgau
October 6th, 2008
Klaus M. Leisinger
Novartis Foundation for Sustainable Development
2. Who defines Corporate Responsibilities today?
Business Environment
Ethics Labor Standards
Pandemics Mass media
Pressure Local
groups communities Human Rights
Shareholders Employees
Public Health
Healthcare Policies
Corporate
Patients
management
Clinical Political Private Pricing
Trials parties Company sector
Physicians Governments Marketing
Practices
Drug / patient safety
Access to Medicines
Pharmacists Suppliers
Neglected Customers Organizations
Diseases
Aging
Science & Patents
Right to Health Academia
Maputo Conference |Klaus M. Leisinger |September 9th,.2008 | | Business Use Only
3. The Request of the UN Global Compact
Human Rights
The Secretary-General asked the world business community to
Principle 1:
support and respect the protection of the international
human rights within their sphere of influence;
Principle 2:
make sure their own corporations are not complicit in
human rights abuses;
Maputo Conference |Klaus M. Leisinger |September 9th,.2008 | | Business Use Only
4. The Preamble
of the Universal Declaration of Human Rights
THIS UNIVERSAL DECLARATION OF HUMAN RIGHTS (has been
proclaimed) as a
“common standard of achievement for all peoples and all
nations, to the end that every individual and every organ of
society, keeping this Declaration constantly in mind, shall strive by
teaching and education to promote respect for these rights and
freedoms and by progressive measures, national and
international, to secure their universal and effective
recognition and observance, both among the peoples of Member
States themselves and among the peoples of territories under their
jurisdiction.” (excerpt from Preamble)
Maputo Conference |Klaus M. Leisinger |September 9th,.2008 | | Business Use Only
5. The Right to Health
Universal Declaration of Human Rights
Article 25.
(1) Everyone has the right to a standard of living adequate for the
health and well-being of himself and of his family, including food,
clothing, housing and medical care and necessary social services,
and the right to security in the event of unemployment, sickness,
disability, widowhood, old age or other lack of livelihood in
circumstances beyond his control.
(2) Motherhood and childhood are entitled to special care and
assistance. All children, whether born in or out of wedlock, shall enjoy
the same social protection.
Maputo Conference |Klaus M. Leisinger |September 9th,.2008 | | Business Use Only
6. International Covenant on Economic, Social and Cultural
Rights
Article 12
1. The States Parties to the present covenant recognize the right of
everyone to the enjoyment of the highest attainable standard of
physical and mental health.
2. The steps to be taken by the States Parties to the present Covenant to
achieve the full realization of this right shall include those necessary
for:
(a) The provision for the reduction of the stillbirth-rate and of infant
mortality and for the healthy development of the child;
(b) The improvement of all aspects of environmental and industrial
hygiene;
(c) The prevention, treatment and control of epidemic, endemic,
occupational and other diseases;
(d) The creation of conditions which would assure to all medical service
and medical attention in the event of sickness.
Maputo Conference |Klaus M. Leisinger |September 9th,.2008 | | Business Use Only
7. The Requests of the Special Rapporteur, e.g.
Pharmaceutical companies should, whenever formulating and
implementing its strategies, policies, programmes, projects and activities
that bear upon access to medicines:
− give particular attention to disadvantaged individuals and
communities, such as those living in poverty;
− give particular attention to gender-related issues;
− give particular attention to the needs of children;
− give particular attention to the very poorest in all markets;
− be transparent;
− encourage and facilitate the participation of all stakeholders,
including disadvantaged individuals and communities.
(guidelines 6(i)-(vi))
Maputo Conference |Klaus M. Leisinger |September 9th,.2008 | | Business Use Only
8.
9.
10. The societal return on pharmaceutical investment
0%
80 Heart Cancer Stroke All causes
Disease
75
Females -10%
-15% -14%
70 Males
-20% -19%
US life expectancy
Years at birth Drop in death rates 1990-2000 among
65 -27% US pop. 45-64
1960 1970 1980 1990 2000 -30%
20
26.%1503 19.7%
0%51982 19
30%
26.2%
15
19.7%
20%
10
10% US pop. > 65 Average length of stay in
5
with disability patient days
0% 0
1982 1999 1960 1970 1980 1990 2000
Sources: OECD Health Data 2004; Health, United States, 2003: Chartbook on Trends in the Health of Americans; Manton KG, Gu X., Proc Natl
Acad Sci USA 2001 May 22; 98(11):6354-9.
Maputo Conference |Klaus M. Leisinger |September 9th,.2008 | | Business Use Only
11.
12. Measuring misery
About 2.5 billion people live on less than
USD 2 a day;
The richest 20% of the world’s population
receive 85% of the global income, the
poorest 20% only 1.4%
Average life expectancy in the poorest
countries of Africa is less than 45 years
Every year more than 500 000 women die
in pregnancy and childbirth – one every
minute
14 million children die every year due to
preventable diseases
Maputo Conference |Klaus M. Leisinger |September 9th,.2008 | | Business Use Only
13. The “difficult” Corporate Responsibility challenges
Market failures and failing states
• Who is in charge if markets fail to help cope with poverty
diseases or if those that are supposed to be in charge are
not delivering – because they are not capable or willing?
• Under which conditions can a business enterprise be
expected to do what for whom until when?
• How much is enough? What is “appropriate” in a world with
2.5 billion people living in absolute poverty? Who has the
legitimacy to determine the “right amounts”?
• Under which conditions is it legitimate to conduct clinical trials in
developing countries?
• etc.
Maputo Conference |Klaus M. Leisinger |September 9th,.2008 | | Business Use Only
16. Corporate Responsibility Tools for
the „Access to Medicine“
Differential Pricing;
Licensing for market failure;
Corporate Philanthropy incl. Donations;
Pro Bono Research;
Screening of Patent Library;
Program Co-operation with Development Institutions
Management Support (Human Resources, Logistics, etc.)
Other innovative and creative private sector skills and methods.
Maputo Conference |Klaus M. Leisinger |September 9th,.2008 | | Business Use Only
18. Novartis is known as a leader in drug access efforts
Leprosy (free to WHO1):
Over four million patients treated since 2000
Malaria / Coartem:
66 million treatments delivered in 2007
Access programs
Tuberculosis (with WHO): worth USD 950
500 000 free treatments provided over five years million reached
66 million
patients in 2007
Glivec2 Patient Assistance Program:
Free therapy to 27 000 people in 80 countries
Novartis Institute for Tropical Diseases:
Singapore-based research initiative
1
World Health Organization
2
Gleevec in US
Maputo Conference |Klaus M. Leisinger |September 9th,.2008 | | Business Use Only
19. Why bother with Access to Medicines issues?
Because it is the right thing to do:
You cannot have a first class economic performance and be
perceived not to care about preventable mortality and morbidity.
Maputo Conference |Klaus M. Leisinger |September 9th,.2008 | | Business Use Only
20. Plausible arguments for a “Business Case”
Applied Corporate Responsibility for Access to Medicines is likely to
Save Lives and prevent morbidity by providing innovative solutions;
Be “part of the solution” of one of the most difficult social issues;
Engender employees’ motivation and identification;
Enhance the attraction of the corporation as a partner for
cooperation, ethical investment, excellent people, and critical
customers).
Maputo Conference |Klaus M. Leisinger |September 9th,.2008 | | Business Use Only